[go: up one dir, main page]

PL1663168T3 - Preparaty nikotyny i ich zastosowanie - Google Patents

Preparaty nikotyny i ich zastosowanie

Info

Publication number
PL1663168T3
PL1663168T3 PL04769203T PL04769203T PL1663168T3 PL 1663168 T3 PL1663168 T3 PL 1663168T3 PL 04769203 T PL04769203 T PL 04769203T PL 04769203 T PL04769203 T PL 04769203T PL 1663168 T3 PL1663168 T3 PL 1663168T3
Authority
PL
Poland
Prior art keywords
nicotine
nicotine formulations
cellulose
formulations
algae
Prior art date
Application number
PL04769203T
Other languages
English (en)
Inventor
Bo Ragnar Ek
Albert Mihranyan
Sven-Börje Andersson
Bengt Ake Bosson
Nils-Olof Lindberg
Original Assignee
Mcneil Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34277854&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1663168(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from SE0302387A external-priority patent/SE0302387D0/xx
Application filed by Mcneil Ab filed Critical Mcneil Ab
Publication of PL1663168T3 publication Critical patent/PL1663168T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL04769203T 2003-09-08 2004-08-27 Preparaty nikotyny i ich zastosowanie PL1663168T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US50106103P 2003-09-08 2003-09-08
SE0302387A SE0302387D0 (sv) 2003-09-08 2003-09-08 Nicotine formulations and use thereof
EP04769203A EP1663168B1 (en) 2003-09-08 2004-08-27 Nicotine formulations and use thereof
PCT/IB2004/002787 WO2005023227A2 (en) 2003-09-08 2004-08-27 Nicotine formulations and use thereof

Publications (1)

Publication Number Publication Date
PL1663168T3 true PL1663168T3 (pl) 2009-07-31

Family

ID=34277854

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04769203T PL1663168T3 (pl) 2003-09-08 2004-08-27 Preparaty nikotyny i ich zastosowanie

Country Status (13)

Country Link
US (1) US20050053665A1 (pl)
EP (1) EP1663168B1 (pl)
JP (1) JP4604034B2 (pl)
AT (1) ATE422355T1 (pl)
AU (1) AU2004269986A1 (pl)
BR (1) BRPI0414196A (pl)
CA (1) CA2537488A1 (pl)
DE (1) DE602004019430D1 (pl)
DK (1) DK1663168T3 (pl)
ES (1) ES2321721T3 (pl)
MX (1) MXPA06002609A (pl)
PL (1) PL1663168T3 (pl)
WO (1) WO2005023227A2 (pl)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2383296A1 (fr) * 2002-05-10 2003-11-10 Ginette Godbout Composition pour l'amelioration de la sante et de la structure des ongles, methode d'utilisation
ES2708552T3 (es) 2002-12-20 2019-04-10 Niconovum Ab Método para la preparación de un material particulado que contiene nicotina con una celulosa cristalina (en particular MCC)
CA2514325C (en) 2003-01-24 2013-11-12 Magle Holding Ab A composition material for transmucosal delivery
US8469036B2 (en) 2003-11-07 2013-06-25 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
DE10356925B4 (de) * 2003-12-05 2006-05-11 Lts Lohmann Therapie-Systeme Ag Inhalator für basische pharmazeutische Wirkstoffe sowie Verfahren für dessen Herstellung
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
JP5254616B2 (ja) 2004-09-13 2013-08-07 クロノ セラピューティクス、インコーポレイテッド 生物学的同調性（ｂｉｏｓｙｎｃｈｒｏｎｏｕｓ）経皮的薬物送達
US20060240084A1 (en) * 2005-04-20 2006-10-26 Xylos Corporation Microbial cellulose materials for use in transdermal drug delivery systems, method of manufacture and use
JP5255449B2 (ja) * 2005-12-06 2013-08-07 エフ エム シー コーポレーション セルロースゲル配合物
JP5694645B2 (ja) * 2006-03-16 2015-04-01 ニコノヴァム エービーＮｉｃｏｎｏｖｕｍ Ａｂ 改善された嗅ぎたばこ組成物
CA2657932A1 (en) * 2006-03-16 2007-09-20 Niconovum Ab Stable lozenge compositions providing rapid release of nicotine
CA2963423C (en) * 2007-03-30 2020-07-28 Philip Morris Products S.A. Device and method for delivery of a medicament
EP2322167A1 (en) * 2007-04-02 2011-05-18 Parkinson's Institute Methods and Compositions for Reduction of Side Effects of Therapeutic Treatments
GB2468424B (en) * 2007-04-02 2011-11-09 Parkinson S Inst Methods and compositions for reduction of side effects of therapeutic treatments
US20080286340A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered nicotine containing products
US20080286341A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered coated nicotine containing products
WO2009037319A2 (en) * 2007-09-18 2009-03-26 Niconovum Ab Stable chewing gum compositions comprising maltitol and providing rapid release of nicotine
BRPI0821608A2 (pt) * 2007-12-11 2015-09-29 Novartis Ag filmes de multizona
EP2230934B8 (en) 2007-12-14 2012-10-24 AeroDesigns, Inc Delivering aerosolizable food products
CL2009001025A1 (es) 2008-05-01 2010-09-24 Smithkline Beecham Corp Composicion de pastilla para chupar que comprende: a) un granulo patron con al menos: un agente tampon alcalino, un modificador de la disolucion y una carga, b) un principio activo de nicotina definido extragranular y al menos un agente tampon alcalino; procedimiento de preparacion; util para eliminar o reducir el uso de tabaco.
AR071850A1 (es) * 2008-05-21 2010-07-21 Novartis Ag Gomas de mascar en forma de tableta
WO2009148442A1 (en) 2008-06-04 2009-12-10 Colgate-Palmolive Company Oral care implement with cavitation system
US20100018541A1 (en) * 2008-07-28 2010-01-28 Anthony Richard Gerardi Smokeless tobacco products and processes
EP2343995B1 (en) * 2008-07-28 2012-08-29 R.J.Reynolds Tobacco Company Smokeless tobacco products and processes
WO2010031552A1 (en) * 2008-09-17 2010-03-25 Niconovum Ab Process for preparing snuff composition
US8506936B2 (en) * 2008-11-25 2013-08-13 Watson Laboratories, Inc. Stabilized nicotine chewing gum
WO2010104464A1 (en) 2009-03-13 2010-09-16 Excellens Tech. Products Aps Oral delivery product
PL2408494T3 (pl) 2009-03-17 2021-11-02 Philip Morris Products S.A. Układ do wytwarzania aerozolu na bazie tytoniu
US8551235B2 (en) 2009-04-23 2013-10-08 Green Wave Innovative Solutions, Llc Algae based fire resistant materials and method of making same
AU2010238945B2 (en) * 2009-04-24 2013-10-24 Omya International Ag Particulate material for controlled release of active ingredients
EP2477607B1 (en) * 2009-09-16 2020-08-05 Philip Morris Products S.a.s. Improved device and method for delivery of a medicament
WO2011101860A1 (en) * 2010-02-18 2011-08-25 Jatin Vasant Thakkar Nicotine-containing soft gelatin pastilles
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
SE535587C2 (sv) * 2011-03-29 2012-10-02 Chill Of Sweden Ab Produkt innehållande ett fritt nikotinsalt och en ej vattenlöslig påse
EP2729148A4 (en) 2011-07-06 2015-04-22 Parkinson S Inst COMPOSITIONS AND METHOD FOR THE TREATMENT OF SYMPTOMS IN PATIENTS WITH MORBUS PARKINSON
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
CN102754908B (zh) 2012-01-20 2015-06-10 奥驰亚客户服务公司 口腔用烟草产品
US9854831B2 (en) 2012-01-20 2018-01-02 Altria Client Services Llc Oral product
CN103039688B (zh) 2012-01-20 2016-01-06 奥驰亚客户服务公司 口腔用产品
CN102754907B (zh) * 2012-01-20 2015-06-24 奥驰亚客户服务公司 口腔用产品
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US20140255452A1 (en) 2013-03-11 2014-09-11 Niconovum Usa, Inc. Method and apparatus for differentiating oral pouch products
CA3208137A1 (en) 2013-05-06 2014-11-13 Juul Labs, Inc. Nicotine salt formulations for aerosol devices and methods thereof
ES2759227T3 (es) 2013-07-19 2020-05-08 Altria Client Services Llc Métodos y sistemas para incorporar nicotina en productos orales
US11503853B2 (en) * 2013-09-09 2022-11-22 R.J. Reynolds Tobacco Company Smokeless tobacco composition incorporating a botanical material
US11779045B2 (en) 2013-10-03 2023-10-10 Altria Client Services Llc Dissolvable-chewable exhausted-tobacco tablet
US10105320B2 (en) 2013-10-03 2018-10-23 Altria Client Services Soluble fiber lozenge
US9351936B2 (en) 2013-10-03 2016-05-31 Altria Client Services Llc Nicotine lozenge
US10244786B2 (en) 2013-10-03 2019-04-02 Altria Client Services Llc Tobacco lozenge
US9999243B2 (en) 2013-10-03 2018-06-19 Altria Client Services Llc Exhausted tobacco lozenge
US12274276B2 (en) 2013-10-03 2025-04-15 Altria Client Services Llc Dissolvable-chewable tablet
AU2014357622B2 (en) * 2013-12-05 2019-10-24 Juul Labs, Inc. Nicotine liquid formulations for aerosol devices and methods thereof
CN113754634A (zh) 2014-05-27 2021-12-07 R.J.雷诺兹烟草公司 烟碱盐、共晶体和盐共晶体络合物
GB201411526D0 (en) * 2014-06-27 2014-08-13 British American Tobacco Co Powder
CA2974324A1 (en) 2015-01-28 2016-08-04 Zita S. Netzel Drug delivery methods and systems
US10679516B2 (en) 2015-03-12 2020-06-09 Morningside Venture Investments Limited Craving input and support system
US9585835B1 (en) 2015-09-16 2017-03-07 Sansa Corporation (Barbados) Inc. Inhalable nicotine formulations and methods of making and using the same
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
GB201602579D0 (en) * 2016-02-12 2016-03-30 Mihranyan Albert New compositions
BR122023020807A2 (pt) 2016-04-12 2023-12-12 Arturo Solis Herrera Uso de agonistas do receptor de acetilcolina nicotínica no tratamento de uma condição de uma membrana mucosa nasal ou paranasal
CN114868950A (zh) 2016-12-30 2022-08-09 菲利普莫里斯生产公司 含有尼古丁的薄片
CA3049529A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
GB201714412D0 (en) * 2017-09-07 2017-10-25 Emplicure Ab Evaporation devices containing plant material
JP7420797B2 (ja) 2018-05-29 2024-01-23 モーニングサイド ベンチャー インベストメンツ リミテッド 薬剤送達の方法及びシステム
EP3807260B1 (en) * 2018-06-15 2024-09-18 R. J. Reynolds Tobacco Company Purification of nicotine
WO2020002689A1 (en) * 2018-06-28 2020-01-02 Philip Morris Products S.A. Cartridge for an aerosol-generating system containing a nicotine source comprising a liquid nicotine formulation
US11432581B2 (en) * 2018-09-07 2022-09-06 Altria Client Services Llc Capsule containing a matrix, device with the matrix, and method of forming the matrix
US11395507B2 (en) 2018-09-07 2022-07-26 Altria Client Services Llc Filter for an e-vaping device, e-vaping device with the filter, and method of forming the filter
US11311048B2 (en) 2018-09-07 2022-04-26 Altria Client Services Llc E-vaping device with an insert
EP3880175A4 (en) 2018-11-16 2022-08-17 Morningside Venture Investments Limited TEMPERATURE-REGULATING TRANSDERMAL DRUG DELIVERY SYSTEM
DK180339B1 (en) * 2019-06-07 2020-12-18 Ncp Nextgen As Nicotine pouch composition and pouch comprising such
AU2020287198C1 (en) 2019-06-07 2025-09-11 Philip Morris Products S.A. Nicotine pouch composition and pouch comprising such
FI3833315T3 (sv) * 2019-10-04 2022-12-15 En påseprodukt lämplig för applicering i munhålan
US11617744B2 (en) 2019-12-09 2023-04-04 Nico Ventures Trading Limited Moist oral compositions
SE544672C2 (en) * 2020-05-07 2022-10-11 Liw Innovation Ab New compositions for oral or nasal use
US12161755B2 (en) 2020-11-14 2024-12-10 Regents Of The University Of Minnesota Sustained release device for treatment of Parkinson's disease and other disorders
EP4014759A1 (en) 2020-12-18 2022-06-22 VIRAofSWEDEN AB Novel product comprising brown alga extract
EP4094594A1 (en) 2021-05-25 2022-11-30 Consumer Brands International s.r.o. A filing of a nicotine formulation, in particular a nicotine sachet and the method of its manufacture, and a mixture of nicotine salts and the method of its manufacture
US12295412B2 (en) 2022-01-28 2025-05-13 Altria Client Services Llc Oral pouch product
WO2023187225A1 (en) 2022-04-01 2023-10-05 Amplicon Ab Alkaline intraoral products

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US59939A (en) * 1866-11-27 Chakles e
US2002218A (en) * 1934-08-22 1935-05-21 Bell Telephone Labor Inc Tie trunk line
DE1517264C3 (de) * 1963-10-31 1978-09-07 Celanese Corp., New York, N.Y. (V.St.A.) Tabakfreies Tabakaustauschmaterial
GB1362611A (en) * 1972-03-14 1974-08-07 Ici Ltd Smoking mixtures
US4748181A (en) * 1979-08-28 1988-05-31 Foundation For Behavioral Research Method for treating hypertension with nicotine
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
WO1986001692A1 (en) * 1984-09-09 1986-03-27 Akiko Kondo Tobacco filter
GB8615676D0 (en) * 1986-06-26 1986-07-30 Stoppers Co Ltd Nicotine containing lozenge
GB8804164D0 (en) * 1988-02-23 1988-03-23 Tucker J M Bandage for administering physiologically active compound
US5824334A (en) * 1989-09-05 1998-10-20 University Of Utah Research Foundation Tobacco substitute
US5167242A (en) * 1990-06-08 1992-12-01 Kabi Pharmacia Aktiebolaq Nicotine-impermeable container and method of fabricating the same
US5135753A (en) * 1991-03-12 1992-08-04 Pharmetrix Corporation Method and therapeutic system for smoking cessation
US6024097A (en) * 1992-02-20 2000-02-15 J Mom Trust Product for assisting a smoker in giving up the habit
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
SE9303574D0 (sv) * 1993-11-01 1993-11-01 Kabi Pharmacia Ab Composition for drug delivery and method the manufacturing thereof
US5810018A (en) * 1994-12-29 1998-09-22 Monte; Woodrow C. Method, composition and apparatus for reducing the incidence of cigarette smoking
JP3687194B2 (ja) * 1996-06-06 2005-08-24 味の素株式会社 水不溶性グルカンの精製方法
CA2319140A1 (en) * 1998-02-06 1999-08-12 Monsanto Company Acid-stable and cationic-compatible cellulose compositions and methods of preparation
US6583160B2 (en) * 1999-04-14 2003-06-24 Steve Smith Nicotine therapy method and oral carrier for assuaging tobacco-addiction
ES2708552T3 (es) * 2002-12-20 2019-04-10 Niconovum Ab Método para la preparación de un material particulado que contiene nicotina con una celulosa cristalina (en particular MCC)
CA2514325C (en) * 2003-01-24 2013-11-12 Magle Holding Ab A composition material for transmucosal delivery

Also Published As

Publication number Publication date
WO2005023227A3 (en) 2005-06-16
ATE422355T1 (de) 2009-02-15
DK1663168T3 (da) 2009-06-08
WO2005023227A2 (en) 2005-03-17
DE602004019430D1 (de) 2009-03-26
EP1663168B1 (en) 2009-02-11
JP2007505037A (ja) 2007-03-08
MXPA06002609A (es) 2006-06-05
BRPI0414196A (pt) 2006-10-31
EP1663168A2 (en) 2006-06-07
ES2321721T3 (es) 2009-06-10
AU2004269986A1 (en) 2005-03-17
CA2537488A1 (en) 2005-03-17
US20050053665A1 (en) 2005-03-10
JP4604034B2 (ja) 2010-12-22

Similar Documents

Publication Publication Date Title
PL1663168T3 (pl) Preparaty nikotyny i ich zastosowanie
WO2006086562A3 (en) Phenylazetidinone derivatives
PL1654253T3 (pl) Podstawione pochodne 3-pirolidynoindolu
CY1107399T1 (el) Μορφη χορηγησης απο του στοματος περιεχουσα προβιοτικα βακτηριδια
DE60327438D1 (de) Amino-substituierte cyclohexan derivate zur behandlung bakterieller infektionen
IL197073A0 (en) Preservative antimicrobial formulations and methods of inhibiting the growth of microorganisms
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
EP1633740A4 (en) CHEMICAL COMPOUNDS
MY143795A (en) Tetrahydropyridoindole derivatives
WO2008039829A3 (en) Diphenylheterocycle cholesterol absorption inhibitors
MY140840A (en) Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
WO2006013441A3 (en) Use of probiotic bacteria for the preparation of topical compositions for skin protection
WO2002069945A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und pde-iv-inhibitoren
WO2005000878A3 (en) Compositions of lipopeptide antibiotic derivatives and methods of use thereof
WO2008064345A3 (en) Microorganism killing compounds
WO2004110376A3 (en) Ccr-2 antagonists for treatment of neuropathic pain
WO2005018605A3 (en) Novel formulation of ropinirole
WO2004091591A3 (fr) Composition nutritionnelle ou therapeutique contenant le compose oleurofeine ou l'un de ses derives
EP1670894B8 (en) Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions
TW200509794A (en) Novel anthelmintic and insecticidal compositions
MX2007005475A (es) Metabolitos de ciertos derivados de [1,4] diazepino [6,7,1-ij] quinolina y metodos de preparacion y uso de los mismos.
WO2003024996A3 (de) Antibakterielle makrozyklen
AU2003291368A1 (en) Compounds for the treatment of tobacco dependence and withdrawal
TW200738599A (en) New pleuromutilin derivative and its use
AU2003274676A1 (en) Antimicrobial oxazolidinones, process of their preparation, and pharmaceutical compositions containing them